We selected three additional genes, PRDM16, ROBO3, and CXCL14, that displayed promoter hypermethylation already in the preleukemic or early leukemic stage (Additional file 4) for validation in human AML samples. This evidence concerns the gene PRDM16 and acute myeloid leukemia.